company

AMWOFARMA AS

1920 SØRUMSAND

Return on Equity
14,42 %
Current Ratio
−19,8
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue973 000
Net Income15 000
Total Assets99 000
Total Equity104 000
Income (NOK)2022
Revenue973 000
Expenditure945 000
Operating Profit28 000
Financial Income0
Financial Costs9 000
Financial Balance−9 000
Earnings Before Tax19 000
Tax4 000
Net Income15 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets99 000
Total Assets99 000
Total Retained Equity74 000
Total Equity104 000
Total Long-Term Debt0
Total Current Debt−5 000
Total Equity and Debt99 000
Cash flow (NOK)2022
Sales Income973 000
Other Income0
Revenue973 000
Cost of Goods Sold848 000
Salary Costs0
Depreciation0
Impairment0
Expenditure945 000
Operating Profit28 000
Financial Income0
Financial Costs9 000
Financial Balance−9 000
Dividends0
Net Income15 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank21 000
Total Current Assets99 000
Total Assets99 000
Total Equity104 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors0
Unpaid Taxes15 000
Dividends0
Other Current Debt−24 000
Total Current Debt−5 000
Total Equity and Debt99 000
Financial indicators2022
Return on Equity14,42 %
Debt-to-Equity Ratio0
Operating Profit Margin2,88 %
Current Ratio−19,8
Quick Ratio−19,8
Equity Ratio1,05
Gross Profit Margin12,85 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English